Head and neck cancer begins in squamous cells that line the mucosal surfaces of the head and neck such as, inside the mouth, the nose, and the throat. The head and neck cancers include specific areas of the body such as oral cavity, pharynx, larynx, paranasal sinuses and nasal cavity, and salivary glands. Alcohol and tobacco are the two most common risk factors for head and neck cancers. Other risk factors for head and neck cancers include consumption of preserved or salted foods, occupational exposure to wood dust, Epstein-Barr virus infection, and poor oral hygiene. Scope of the Report: This report studies the Head and Neck Cancer Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Head and Neck Cancer Diagnostics market by product type and applications/end industries. The market for head and neck cancer diagnostics is expected to increase year on year with an increasing incidence of the disease. Though this form of cancer is not prevalent in all its forms in the US, it has increased presence and incidence in countries of Asia, Africa and to some extent Europe, making its screening and early detection of high importance to affect proper treatment and care. Proper detection at an early stage can lead to proper treatment and long healthier life. Rise in the aging population that increased the prevalence of chronic diseases, especially head and neck related cancers, increasing awareness towards cancer, and rise in the healthcare expenditure of people and government. However, Low Adoption Rate of Digital Technology Based Systems, Conventional CT and MRI Scanners, Excise Duty Imposed on Sale of Medical Devices in Mature Markets Africa and Asia-Pacific, along with parts of Europe, and certain regions in South America, have the highest incidence of head and neck cancer cases, as these regions are prone to higher intake of alcohol and tobacco products. In Asia-Pacific and Africa, India, China, and South Africa are the biggest markets for the overall?head and neck cancer diagnostics market.? The global Head and Neck Cancer Diagnostics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Head and Neck Cancer Diagnostics. Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%. Market Segment by Companies, this report covers GE Healthcare Philips Healthcare Siemens Healthcare Varian Medical Systems Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Diagnostic Imaging Endoscopy Screening Bioscopy Screening Blood Tests Dental Diagnostic Others Market Segment by Applications, can be divided into Hospitals Specialty Clinics Ambulatory Surgical Centers
Table of Contents 1 Head and Neck Cancer Diagnostics Market Overview 1.1 Product Overview and Scope of Head and Neck Cancer Diagnostics 1.2 Classification of Head and Neck Cancer Diagnostics by Types 1.2.1 Global Head and Neck Cancer Diagnostics Revenue Comparison by Types (2017-2023) 1.2.2 Global Head and Neck Cancer Diagnostics Revenue Market Share by Types in 2017
